Hemato Oncology
Medical Oncology Center
Brain tumor
,
Clinical trial
,
Precision Medicine
,
Lung cancer
,
Lymphoma
Precision Medicine
Lung cancer
,
Lymphoma
,
Brain tumor
,
Clinical trial
,
Precision Medicine
Education / Career
| Article | A phase II study of brentuximab vedotin in patients with relapsed or refractory Epstein-Barr virus-positive and CD30-positive lymphomas | ||
|---|---|---|---|
| Announcements | Haematologica | Date of publication | 2021 |
| Co-researcher | Kim M, Lee JO, Kim TM, et al. | ||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/33792222/ | ||
| Article | Acquired Resistance to Third-Generation EGFR Tyrosine Kinase Inhibitors in Patients With De Novo EGFR T790M-Mutant NSCLC | ||
|---|---|---|---|
| Announcements | J Thorac Oncol | Date of publication | 2021 |
| Co-researcher | Park HR, Kim TM, Lee Y, et al. | ||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/34242789/ | ||
| ETC URL | https://pubmed.ncbi.nlm.nih.gov/34242789/ | ||
| Article | Clinical and Genomic Characteristics of Adult Diffuse Midline Glioma | ||
|---|---|---|---|
| Announcements | Cancer Res Treat | Date of publication | 2020 |
| Co-researcher | Park C, Kim TM, Bae JM, et al. | ||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/33171023/ | ||
| Article | Preclinical Modeling of Osimertinib for NSCLC With EGFR Exon 20 Insertion Mutations | ||
|---|---|---|---|
| Announcements | J Thorac Oncol | Date of publication | 2019 |
| Co-researcher | Lee Y, Kim TM, Kim DW, et al. | ||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/31108249/ | ||
| Article | Clinical observation of lymphopenia in patients with newly diagnosed glioblastoma | ||
|---|---|---|---|
| Announcements | J Neurooncol | Date of publication | 2019 |
| Co-researcher | Kim WJ, Dho YS, Ock CY, et al. | ||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/30982199/ | ||
| Article | Combined blockade of polo-like kinase and pan-RAF is effective against NRAS-mutant non-small cell lung cancer cells | ||
|---|---|---|---|
| Announcements | Cancer Letters | Date of publication | 2019 |
| Co-researcher | Park S, Kim TM, Cho SY, et al. | ||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/32979462/ | ||
| Article | Clinicopathological and Preclinical Findings of NUT Carcinoma: A Multicenter Study | ||
|---|---|---|---|
| Announcements | Oncologist | Date of publication | 2019 |
| Co-researcher | Jung M, Kim S, Lee JK, et al. | ||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/30696721/ | ||
| Article | Long-term effects of crizotinib in ALK-positive tumors (excluding NSCLC): A phase 1b open-label study | ||
|---|---|---|---|
| Announcements | Am J Hematol | Date of publication | 2018 |
| Co-researcher | Gambacorti-Passerini C, Orlov S, Zhang L, et al. | ||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/29352732/ | ||
| Article | Phase 1 Studies of Poziotinib, an Irreversible Pan-HER Tyrosine Kinase Inhibitor in Patients with Advanced Solid Tumors | ||
|---|---|---|---|
| Announcements | Cancer Res Treat | Date of publication | 2018 |
| Co-researcher | Kim TM, Lee KW, Oh DY, et al. | ||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/28859471/ | ||
| Article | Comparison of Native Escherichia Coli L-Asparaginase Versus Pegylated Asparaginase, in Combination with Ifosfamide, Methotrexate, Etoposide, and Prednisolone (IMEP), in Extranodal NK/T Cell Lymphoma, Nasal Type (NTCL) | ||
|---|---|---|---|
| Announcements | Cancer Res Treat | Date of publication | 2018 |
| Co-researcher | Kim HJ, Ock CY, Kim TM, et al. | ||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/28675023/ | ||
| Article | A Phase II Trial of Pazopanib in Patients with Metastatic Alveolar Soft Part Sarcoma | ||
|---|---|---|---|
| Announcements | Oncologist | Date of publication | 2018 |
| Co-researcher | Kim M, Kim TM, Keam B, et al. | ||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/30254189/ | ||
| Article | Clinicopathological categorization of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications | ||
|---|---|---|---|
| Announcements | Leuk Lymphoma | Date of publication | 2017 |
| Co-researcher | Paik JH, Choe YJ, Kim H, et al. | ||
| Article | Complex Chromosomal Rearrangements by Single Catastrophic Pathogenesis in NUT Midline Carcinoma | ||
|---|---|---|---|
| Announcements | Ann Oncol | Date of publication | 2017 |
| Co-researcher | Lee JK, Louzada S, An Y, et al. | ||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/28203693/ | ||
| Article | Clonal History and Genetic Predictors of Transformation into Small Cell Carcinomas from Lung Adenocarcinomas | ||
|---|---|---|---|
| Announcements | J Clin Oncol | Date of publication | 2017 |
| Co-researcher | Lee JK, LeeJ, Kim S, et al. | ||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/28498782/ | ||
| Article | Novel JAK3-Activating Mutations in Extranodal NK/T-cell Lymphoma, Nasal Type | ||
|---|---|---|---|
| Announcements | Am J Pathol | Date of publication | 2017 |
| Co-researcher | Sim SH, Kim S, Kim TM, et al. | ||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/28284718/ | ||
| Article | Phase I study of random, healthy donor-derived allogeneic natural killer cell therapy in patients with malignant lymphoma or advanced solid tumors | ||
|---|---|---|---|
| Announcements | Cancer Immunol Res | Date of publication | 2016 |
| Co-researcher | Yang Y, Lim O, Kim TM, et al. | ||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/26787822/ | ||
| Article | Mechanisms of Acquired Resistance to AZD9291, a Mutation-Selective, Irreversible EGFR Inhibitor | ||
|---|---|---|---|
| Announcements | J Thorac Oncol | Date of publication | 2015 |
| Co-researcher | Kim TM, Song A, Kim DW, et al. | ||
| Article | Total Lesion Glycolysis in Positron Emission Tomography Can Predict Gefitinib Outcomes in Non-Small-Cell Lung Cancer with Activating EGFR Mutation | ||
|---|---|---|---|
| Announcements | J Thorac Oncol | Date of publication | 2015 |
| Co-researcher | Keam B, Lee SJ, Kim TM, et al. | ||
| Article | Molecular changes associated with acquired resistance to crizotinib in ROS1-rearranged non-small cell lung cancer (NSCLC) | ||
|---|---|---|---|
| Announcements | Clin Cancer Res | Date of publication | 2015 |
| Co-researcher | Song A, Kim TM, Kim DW, et al. | ||
| Article | Ifosfamide, methotrexate, etoposide, and prednisolone (IMEP) plus L-asparaginase as a first-line therapy improves outcomes in stage III/IV NK/T cell-lymphoma, nasal type (NTCL) | ||
|---|---|---|---|
| Announcements | Ann Hematol | Date of publication | 2015 |
| Co-researcher | Kim M, Kim TM, Kim KH, et al. | ||
| Article | An NMR metabolomics approach for the diagnosis of leptomeningeal carcinomatosis in lung adenocarcinoma cancer patients | ||
|---|---|---|---|
| Announcements | Int J Cancer | Date of publication | 2015 |
| Co-researcher | An YJ, Cho HR, Kim TM, et al. | ||
| Article | A Phase II Study of Ifosfamide, Methotrexate, Etoposide, and Prednisolone for Previously Untreated Stage I/II Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Multicenter Trial of the Korean Cancer Study Group | ||
|---|---|---|---|
| Announcements | Oncologist | Date of publication | 2014 |
| Co-researcher | Kim TM, Kim DW, Kang YK, et al. | ||
| Article | Anti-cancer activity of gemcitabine against natural killer (NK) cell leukemia-lymphoma | ||
|---|---|---|---|
| Announcements | Leuk Lymphoma | Date of publication | 2014 |
| Co-researcher | Kim TM, Kim S, Ahn YO, et al. | ||
| Article | Heterogeneity of Genetic Changes Associated with Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancer. | ||
|---|---|---|---|
| Announcements | J Thorac Oncol | Date of publication | 2013 |
| Co-researcher | Kim S, Kim TM, Kim DW, et al. | ||
| Article | Multiplexed Gene Expression and Fusion Transcript Analysis to Detect ALK Fusions in Lung Cancer. | ||
|---|---|---|---|
| Announcements | J Mol Diagn | Date of publication | 2013 |
| Co-researcher | Lira ME, Kim TM, Huang D, et al | ||
| Article | Total lesion glycolysis in positron emission tomography is a better predictor of outcome than the International Prognostic Index for patients with diffuse large B-cell lymphoma. | ||
|---|---|---|---|
| Announcements | Cancer | Date of publication | 2013 |
| Co-researcher | Kim TM, Paeng JC, Chun IK, et al. | ||
| Article | Tumor Burden is Predictive of Survival in Patients With Non-Small-Cell Lung Cancer and With Activating Epidermal Growth Factor Receptor Mutations Who Receive Gefitinib. | ||
|---|---|---|---|
| Announcements | Clin Lung Cancer | Date of publication | 2013 |
| Co-researcher | Park JH, Kim TM, Keam B, et al. | ||
| Article | Differential sensitivities to tyrosine kinase inhibitors in NSCLC harboring EGFR mutation and ALK translocation. | ||
|---|---|---|---|
| Announcements | Lung Cancer | Date of publication | 2012 |
| Co-researcher | Lee JK, Kim TM, Koh Y, et al. | ||
| Article | Anaplastic Lymphoma Kinase (ALK) Translocation: A Predictive Biomarker of Pemetrexed in Patients with Non-small Cell Lung Cancer | ||
|---|---|---|---|
| Announcements | J Thorac Oncol | Date of publication | 2011 |
| Co-researcher | Lee JO, Kim TM, Lee SH, et al. | ||
| Article | First-line therapy with doxycycline in ocular adnexal MALT lymphoma: a retrospective analysis of clinical predictors | ||
|---|---|---|---|
| Announcements | Cancer Sci | Date of publication | 2010 |
| Co-researcher | Kim TM, Kim KH, Lee MJ, et al. | ||
| Article | Clinical predictors of recurrent venous thromboembolism: a single institute experience in Korea | ||
|---|---|---|---|
| Announcements | Thromb Res | Date of publication | 2009 |
| Co-researcher | Kim TM, Kim JS, Han SW, et al | ||
| Article | Extranodal NK / T-cell lymphoma, nasal type: New staging system and treatment strategies. | ||
|---|---|---|---|
| Announcements | Cancer Sci | Date of publication | 2009 |
| Co-researcher | Kim TM, Heo DS | ||
| Article | Clinical heterogeneity of extranodal NK/T-cell lymphoma, nasal type: a national survey of the Korean Cancer Study Group | ||
|---|---|---|---|
| Announcements | Ann Oncol | Date of publication | 2008 |
| Co-researcher | Kim TM, Lee SY, Jeon YK, et al | ||
| Article | Local tumor invasiveness is more predictive of survival than international prognostic index in stage IE/IIE extranodal NK/T-cell lymphoma, nasal type | ||
|---|---|---|---|
| Announcements | Blood | Date of publication | 2005 |
| Co-researcher | Kim TM, Park YH, Lee SY, et al | ||